Hypoglycemia – a condition in which low blood glucose levels can cause you to feel dizzy, weak, and shaky – can catch you by ...

MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 ...

For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...

MIT’s wireless skin implant delivers glucagon instantly when blood sugar drops, offering new safety for diabetics, even while ...

Medically reviewed by Qin Rao, MD Weight loss drugs like Wegovy (semaglutide) and Zepbound (tirzepatide) have been associated with hair loss. While these drugs do not directly cause hair loss, rapid ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

GLUCAGON, a polypeptide hormone produced by the alpha cells of the pancreas, acts primarily in the liver to increase cyclic adenosine monophosphate (AMP), promoting glycogenolysis through ...

Engineers at MIT have created a coin-sized implant that automatically dispenses glucagon, a life-saving drug for diabetics, when blood glucose levels drop dangerously low.

It can lead to dizziness, confusion, seizures, or even coma if not treated quickly. To help prevent this, scientists have ...

Altimmune’s pemvidutide failed to significantly improve fibrosis in MASH patients in a Phase IIb study. The biotech crashed ...